[go: up one dir, main page]

ID24358A - Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen - Google Patents

Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen

Info

Publication number
ID24358A
ID24358A IDW991188A ID991188A ID24358A ID 24358 A ID24358 A ID 24358A ID W991188 A IDW991188 A ID W991188A ID 991188 A ID991188 A ID 991188A ID 24358 A ID24358 A ID 24358A
Authority
ID
Indonesia
Prior art keywords
prostatic
propilactic
benost
treatment
selective modulators
Prior art date
Application number
IDW991188A
Other languages
English (en)
Indonesian (id)
Inventor
Blake Lee Neubauer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID24358A publication Critical patent/ID24358A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IDW991188A 1997-04-09 1998-04-07 Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen ID24358A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4322397P 1997-04-09 1997-04-09

Publications (1)

Publication Number Publication Date
ID24358A true ID24358A (id) 2000-07-13

Family

ID=21926126

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991188A ID24358A (id) 1997-04-09 1998-04-07 Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen

Country Status (16)

Country Link
EP (1) EP0975629A4 (no)
JP (1) JP2001518900A (no)
KR (1) KR20010006218A (no)
CN (1) CN1259944A (no)
AU (1) AU6966198A (no)
BR (1) BR9808515A (no)
CA (1) CA2286204A1 (no)
EA (1) EA199900914A1 (no)
HU (1) HUP0003589A3 (no)
ID (1) ID24358A (no)
IL (1) IL132277A0 (no)
NO (1) NO994903L (no)
PL (1) PL336205A1 (no)
TR (1) TR199902701T2 (no)
WO (1) WO1998045288A1 (no)
ZA (1) ZA982819B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6610706B1 (en) 1999-07-29 2003-08-26 Eli Lilly And Company Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
US6653479B1 (en) 1999-07-29 2003-11-25 Eli Lilly And Company Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride
EP1392304A1 (en) * 2001-05-10 2004-03-03 Cedars Sinai Medical Center Use of benzothiophenes to treat and prevent prostate cancer
US7425565B2 (en) * 2002-05-09 2008-09-16 Cedars-Sinai Medical Center Use of benzothiopenes to treat and prevent prostate cancer
US7825107B2 (en) * 2006-05-22 2010-11-02 Hormos Medical Ltd. Method of treating men suffering from chronic nonbacterial prostatitis with SERM compounds or aromatase inhibitors
EA022760B1 (ru) 2007-10-16 2016-02-29 Репрос Терапьютикс Инк. Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
AU2013225869B2 (en) 2012-02-29 2017-06-08 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
MA38325B1 (fr) 2013-02-19 2019-03-29 Novartis Ag Dérivés de benzothiophène et compositions correspondantes en tant qu'agents de dégradation sélectifs des récepteurs des œstrogènes
JP7048505B2 (ja) 2015-11-10 2022-04-05 パラクリン セラピューティクス エービー Ｐｄｇｆ－ｃｃ阻害剤および抗エストロゲン剤によるｅｒ陰性乳癌の処置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429922A (en) * 1988-03-09 1995-07-04 The Board Of Trustees Of The Leland Stanford Junior University Composition and method for distinguishing virulent and non-virulent toxoplasma infections
JP3989569B2 (ja) * 1995-02-28 2007-10-10 イーライ リリー アンド カンパニー ベンゾチオフェン化合物、中間体、組成物および方法
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
US5731342A (en) * 1996-02-22 1998-03-24 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods

Also Published As

Publication number Publication date
PL336205A1 (en) 2000-06-05
AU6966198A (en) 1998-10-30
HUP0003589A3 (en) 2002-02-28
EP0975629A4 (en) 2001-03-21
NO994903L (no) 1999-12-09
JP2001518900A (ja) 2001-10-16
CA2286204A1 (en) 1998-10-15
WO1998045288A1 (en) 1998-10-15
NO994903D0 (no) 1999-10-08
EP0975629A1 (en) 2000-02-02
ZA982819B (en) 1999-10-04
IL132277A0 (en) 2001-03-19
BR9808515A (pt) 2001-06-19
KR20010006218A (ko) 2001-01-26
EA199900914A1 (ru) 2000-04-24
HUP0003589A2 (hu) 2002-01-28
TR199902701T2 (xx) 2000-02-21
CN1259944A (zh) 2000-07-12

Similar Documents

Publication Publication Date Title
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
DE69927084D1 (de) Sigma-delta Modulator und Modulationsverfahren
DK0968208T3 (da) Quinolin- og quinazolin-forbindelser som er nyttige i terapi især til behandling af godartet prostatisk hyperplasia
DK0925069T3 (da) Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer
DE69709255D1 (de) Polarisationsunabhängiger elektrooptischer modulator
ID27614A (id) Metode dan radas untuk terapi gelombang
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
EP0909067A4 (en) MODULATOR AND MODULATION PROCESS
ID24358A (id) Pengobatan atau propilaksis dari kanker prostatik dan hiperplasia prostatik benign dengan modulator selektif reseptor estrogen
NO20011162L (no) Fremgangsmåter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset
DE69830435D1 (de) Räumlischer LichtModulator und Anzeige
ID23159A (id) Wafer dan pembuatannya
DE69802158D1 (de) Doppelgegentaktmodulator und vier Phasen Modulationseinrichtung
ID26873A (id) Kombinasi terapeutik yang terdiri dari modulator reseptor estrogen selektif dan hormon paratiroid
ID23163A (id) Turunan-turunan piridina dan komposisi-komposisi farmasi yang mengandungnya
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
ID23653A (id) Pencegahan kanker payudara dengan modulator reseptor estrogen selektif
DE69831626D1 (de) Datenmodulation und -übertragung
ID18913A (id) Turunan turunan tienopiridin dan penggunaannya
ID22345A (id) Penghilangan 6-aminokapronitril dari campuran-campuran yang terdiri dari 6-aminokapronitril dan suatu imina
AU6570998A (en) Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis
ID22685A (id) Penghilangan 6-aminokapronitril dari campuran yang terdiri dari 6-aminokapronitril dan imina
NO975838D0 (no) Melatoninagonister for behandling av godartet prostatisk hyperplasi
DE69820650D1 (de) Verbesserter alginatmischer